Old Web
English
Sign In
Acemap
>
authorDetail
>
Heather Shaw
Heather Shaw
The Royal Marsden NHS Foundation Trust
Pharmacokinetics
Immunology
Pharmacology
Biology
Tolerability
3
Papers
14
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Phase Ib study of telatinib (BAY 57-9352), a VEGFR-2 inhibitor, in combination with docetaxel in patients with advanced solid tumors
2007
Molecular Cancer Therapeutics
Heather Shaw
R. Molife
Vasilios Karavasilis
Teng Ong
Laura Tate
Peter C.C. Fong
Tim Yap
R. Lal
Catherine Ludwig
Erich Brendel
Olaf Christensen
Johann S. de Bono
Show All
Source
Cite
Save
Citations (0)
An exploration of the ability of DCE-CT scans to evaluate blood flow in an open, pharmacokinetic (PK) and mass balance study of 14[C]-cediranib
2007
Molecular Cancer Therapeutics
Alison Reid
Adrian Tang
James Spicer
Elisa Gallerani
Dorothy Mears
Heather Shaw
Vasilios Karavasilis
Sarah Settatree
Timothy A. Yap
Cheryl Marriot
Thomas Puchalski
Mike Harrison
Jo Naish
Helen Mann
Johann De-Bono
Show All
Source
Cite
Save
Citations (2)
Phase I dose-escalation study of ZK 304709, an oral multi-target tumor growth inhibitor (MTGI), administered for 14 days of a 28-day cycle
2006
Journal of Clinical Oncology
S. Ahmed
R. Molife
Heather Shaw
William P. Steward
Anne Thomas
M. Barrett
Kristin Kowal
Candice McCoy
Johann De-Bono
Show All
Source
Cite
Save
Citations (12)
1